Research programme: atherosclerosis therapies - Cardiovascular Research Institute Maastricht/Organon
Alternative Names: Atherosclerosis therapies research programme - Cardiovascular Research Institute Maastricht/OrganonLatest Information Update: 02 Jul 2007
At a glance
- Originator Cardiovascular Research Institute Maastricht; Organon
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis
Most Recent Events
- 25 Sep 2006 No development reported - Preclinical for Atherosclerosis in Netherlands (unspecified route)
- 02 Dec 2003 Preclinical trials in Atherosclerosis in Netherlands (unspecified route)